Cargando…
Critical appraisal of trastuzumab in treatment of advanced stomach cancer
Advanced or metastatic gastric cancer constitutes the majority of patients in clinical practice. In North America, about 70% of cases are advanced or metastatic when diagnosed, which is higher than the 50% reported in Japan. This difference in presentation is reflected in 5-year overall survival, wh...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085240/ https://www.ncbi.nlm.nih.gov/pubmed/21556317 http://dx.doi.org/10.2147/CMR.S12698 |